{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:22:12Z","timestamp":1770988932981,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Rajavithi Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pac J Clin Oncol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1111\/ajco.12495","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T10:39:03Z","timestamp":1461235143000},"page":"289-299","source":"Crossref","is-referenced-by-count":14,"title":["Intravenous versus oral dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in patients with primary ovarian, fallopian tube and peritoneal cancer: A double-blind randomized controlled trial"],"prefix":"10.1111","volume":"12","author":[{"given":"Marut","family":"Yanaranop","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Rajavithi Hospital"},{"name":"College of Medicine; Rangsit University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasith","family":"Chaithongwongwatthana","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine; Chulalongkorn University; Bangkok Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"10.1111\/ajco.12495-BIB0001|ajco12495-cit-0001","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA: CA Cancer J Clin"},{"issue":"Suppl 8","key":"10.1111\/ajco.12495-BIB0002|ajco12495-cit-0002","doi-asserted-by":"crossref","first-page":"viii7","DOI":"10.1093\/annonc\/mdi961","article-title":"2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","volume":"16","author":"du Bois","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1111\/ajco.12495-BIB0003|ajco12495-cit-0003","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","article-title":"Hypersensitivity reactions from taxol","volume":"8","author":"Weiss","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajco.12495-BIB0004|ajco12495-cit-0004","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/ajco.12495-BIB0005|ajco12495-cit-0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"10.1111\/ajco.12495-BIB0006|ajco12495-cit-0006","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1345\/aph.10287","article-title":"Prophylaxis for paclitaxel hypersensitivity reactions","volume":"35","author":"Kintzel","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1111\/ajco.12495-BIB0007|ajco12495-cit-0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00280-004-0924-9","article-title":"Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy","volume":"56","author":"Sendo","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/ajco.12495-BIB0008|ajco12495-cit-0008","first-page":"2486","article-title":"Phase I clinical and pharmacokinetic study of taxol","volume":"47","author":"Wiernik","year":"1987","journal-title":"Cancer Res"},{"key":"10.1111\/ajco.12495-BIB0009|ajco12495-cit-0009","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1023\/A:1008207025430","article-title":"Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions","volume":"8","author":"Bookman","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1111\/ajco.12495-BIB0010|ajco12495-cit-0010","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/IGC.0b013e31829f1799","article-title":"Intravenous versus oral dexamethasone premedication in preventing Paclitaxel infusion hypersensitivity reactions in gynecological malignancies","volume":"23","author":"O'Cathail","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1111\/ajco.12495-BIB0011|ajco12495-cit-0011","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/oxfordjournals.annonc.a010806","article-title":"Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel","volume":"7","author":"Gennari","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1111\/ajco.12495-BIB0012|ajco12495-cit-0012","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/gyno.1998.4993","article-title":"Single-dose dexamethasone paclitaxel premedication","volume":"69","author":"Micha","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajco.12495-BIB0013|ajco12495-cit-0013","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s004320050297","article-title":"An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions","volume":"125","author":"Markman","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/ajco.12495-BIB0014|ajco12495-cit-0014","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1006\/gyno.2001.6546","article-title":"A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel","volume":"84","author":"Kwon","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1111\/ajco.12495-BIB0015|ajco12495-cit-0015","first-page":"77","article-title":"A simplified premedication schedule for 1-hour paclitaxel administration","volume":"3","author":"Tsavaris","year":"2005","journal-title":"J Support Oncol"},{"key":"10.1111\/ajco.12495-BIB0016|ajco12495-cit-0016","first-page":"CR462","article-title":"A simplified premedication protocol for one-hour paclitaxel infusion in various combinations","volume":"12","author":"Kosmas","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1111\/ajco.12495-BIB0017|ajco12495-cit-0017","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"10.1111\/ajco.12495-BIB0018|ajco12495-cit-0018","unstructured":""},{"key":"10.1111\/ajco.12495-BIB0019|ajco12495-cit-0019","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/ajco.12495-BIB0020|ajco12495-cit-0020","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2001.19.6.1809","article-title":"Reliability and validity of the functional assessment of cancer therapy-ovarian","volume":"19","author":"Basen-Engquist","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajco.12495-BIB0021|ajco12495-cit-0021","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/sim.4780131308","article-title":"Interim analysis: The alpha spending function approach","volume":"13","author":"DeMets","year":"1994","journal-title":"Stat Med"},{"key":"10.1111\/ajco.12495-BIB0022|ajco12495-cit-0022","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/028418602320404998","article-title":"Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum","volume":"41","author":"Rosenberg","year":"2002","journal-title":"Acta Oncol"},{"key":"10.1111\/ajco.12495-BIB0023|ajco12495-cit-0023","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/00912700122010285","article-title":"Pharmacokinetics and pharmacodynamics of dexamethasone sodium-m-sulfobenzoate (DS) after intravenous and intramuscular administration: a comparison with dexamethasone phosphate (DP)","volume":"41","author":"Hochhaus","year":"2001","journal-title":"J Clin Pharmacol"}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajco.12495","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajco.12495\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T07:57:29Z","timestamp":1625299049000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajco.12495"}},"subtitle":["Dexamethasone and paclitaxel-associated HSR"],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1111\/ajco.12495","archive":["Portico"],"relation":{},"ISSN":["1743-7555"],"issn-type":[{"value":"1743-7555","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}